본문 바로가기
KERD
논문KCI 등재

Successful Pamidronate Treatment of Osteogenesis Imperfecta Type III Infant with Multiple Fractures

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류소아과학

초록

Osteogenesis imperfect (OI) is a generalized connective tissue disorder. We report the female neonate case with OI type III who showed severe bone deformities and fractures in utero. At birth, she showed multiple fractures in the clavicle, rib, femur, and wormian bone in the skull X-ray. We initiated pamidronate disodium infusion 30 mg/m2 in cycles of 3 consecutive days from when she was 4 days old, monthly for the first 3months and every 2 months thereafter without adverse effects.

Abstract

Osteogenesis imperfect (OI) is a generalized connective tissue disorder. We report the female neonate case with OI type III who showed severe bone deformities and fractures in utero. At birth, she showed multiple fractures in the clavicle, rib, femur, and wormian bone in the skull X-ray. We initiated pamidronate disodium infusion 30 mg/m2 in cycles of 3 consecutive days from when she was 4 days old, monthly for the first 3months and every 2 months thereafter without adverse effects.

참고문헌 (15)

  1. Marini JC, "Osteogenesis imperfecta, In Nelson Textbook of Pediatrics, 19th ed", pp.2437~2440 (2011), Saunders
  2. Sykes B, "Consistent linkage of dominantly inherited osteogenesis imperfecta to the type I collagen loci: COL1A1 and COL1A2", Am J Hum Genet, 46, pp.293~307 (1990)
  3. Barr DGD, "Disorders of bone, joints and connective tissue, In Forfar and Arneil’s Textbook of Pediatrics, 5th Ed", pp.1567~1570 (1998), Churchill Livingstone
  4. Mondal RK, "Osteogenesis imperfecta with bleeding diathesis", Indian J Pediatr, 70, pp.95~96 (2003)
  5. Rauch F, "Osteogenesis imperfecta", Lancet, 363, pp.1377~1385 (2004)
  6. Marini JC, "Positive linear growth and bone responses to growth hormone treatment in children with types III and IV osteogenesis imperfecta: high predictive value of the carboxyterminal propeptide of type I procollagen", J Bone Miner Res, 18, pp.237~243 (2003)
  7. Glorieux FH, "Cyclic administration of pamidronate in children with severe osteogenesis imperfecta", N Engl J Med, 339, pp.947~952 (1998)
  8. Aström E, "Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta", Arch Dis Child, 86, pp.356~364 (2002)
  9. Lee YS, "Cyclic pamidronate infusion improves bone mineralisation and reduces fracture incidence in osteogenesis imperfecta", Eur J Pediatr, 160, pp.641~644 (2001)
  10. Wijewardena SK, "Bisphosphonate treatment for type III osteogenesis imperfecta in Lady Ridgeway Hospital, Colombo, Sri Lanka", Sri Lanka J Child Health, 39, pp.44~46 (2010)
  11. DiMeglio LA, "Two-year clinical trial of oral alendronate versus intravenous pamidronate in children with osteogenesis imperfecta", J Bone Miner Res, 21, pp.132~140 (2006)
  12. Sakkers R, "Skeletal effects and functional outcome with olpadronate in children with osteogenesis imperfecta: a 2-year randomized placebo-controlled study", Lancet, 363, pp.1427~1431 (2004)
  13. Falk MJ, "Intravenous bisphosphonate therapy in children with osteogenesis imperfecta", Pediatrics, 111, pp.573~578 (2003)
  14. Rauch F, "The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta", J Clin Invest, 110, pp.1293~1299 (2002)
  15. Jakubowska-Pietkiewicz E, "New trends in the treatment of osteogenesis imperfecta type III - own experience", Ortop Traumatol Rehabil, 10, pp.593~601 (2008)

관련 논문AI추천

Genotype-phenotype correlations and long-term efficacy of pamidronate therapy in patients with osteogenesis imperfecta이범희, 최진호, Choi Yunha, Hwang Soojin, Kim Gu-Hwan, Yoo Han-Wook대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2022 · 제27권 제1호Efficacy and safety of intravenous pamidronate infusion for treating osteoporosis in children and adolescentsChoi Jin-Ho, Choi Yunha, Lee Yena, Yoo Han-Wook, Yoon Ji-Hee대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2021 · 제26권 제2호Zoledronate Therapy in Osteogenesis Imperfecta: Perspectives in Indonesia Tertiary HospitalAliefio Japamadisaw, Dian Nurhayati, Rob G. H. H. Nelissen, Tri Wahyu Martanto대한골대사학회 · 대한골대사학회지2024 · 제31권 제4호Denosumab use in osteogenesis imperfecta: an update on therapeutic approachesFerjani Hanene Lassoued, Hamdi Wafa, Kaffel Dhia, Maatallah Kaouther, Majdoub Fatma, Nessib Dorra Ben대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2023 · 제28권 제2호Effectiveness and safety of pamidronate treatment in nonambulatory children with low bone mineral densityChae Hyun Wook, Choi Han Saem, Kim Ho-Seong, Kwon Ahreum, Lee Hae In, Lee Myeongseob, Song Kyungchul, Suh Junghwan대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2024 · 제29권 제1호소아청소년기 이차성 골다공증 환자에서의 파미드로네이트 치료신충호, 양세원, 윤주영, 이영아, 이지은, 임중섭대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2011 · 제16권 제3호

이 간행물의 다른 논문 (9건)